We are live on
!
Find out more
WP
Waycross Partners Portfolio holdings
AUM
$1.05B
1-Year Est. Return
20.92%
This Fund
S&P 500
This Quarter
Est. Return
+3.22%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
–
AUM
$723M
AUM Growth
+$71.6M
(+11%)
Cap. Flow
+$55.5M
Cap. Flow
% of AUM
7.68%
Top 10 Holdings %
Top 10 Hldgs %
48.37%
Holding
74
New
3
Increased
27
Reduced
3
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$18M |
| 2 |
Adobe
ADBE
|
+$17.3M |
| 3 |
Dollar General
DG
|
+$16.5M |
| 4 |
CSX Corp
CSX
|
+$9.13M |
| 5 |
Honeywell
HON
|
+$5.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$13.8M |
| 2 |
Dollar Tree
DLTR
|
+$12.4M |
| 3 |
Norfolk Southern
NSC
|
+$12M |
| 4 |
CVS Health
CVS
|
+$5.94M |
| 5 |
Stryker
SYK
|
+$2.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.94% |
| 2 | Healthcare | 16.42% |
| 3 | Financials | 13.93% |
| 4 | Consumer Discretionary | 11.37% |
| 5 | Communication Services | 10.27% |
Similar funds
RC
LPC
ANBT
HWCM
AA
AAIM
CIA
TPWA
Waycross Partners's Q3 2024 Portfolio in Review
As of Q3 2024, Waycross Partners held 74 positions worth $723M, up 11% from $652M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Waycross Partners deployed $55.5M of net new capital in Q3 2024, opening 3 new positions and adding to 27 existing holdings. Its largest new stake was Becton Dickinson: 76,961 shares worth $18.6M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $5.94M trimmed.
- Waycross Partners's largest Q3 2024 buy was Becton Dickinson: 76,961 shares worth $18.6M.
- Waycross Partners added most to Dollar General in Q3 2024, an estimated $16.5M increase.
- Waycross Partners's biggest Q3 2024 reduction was CVS Health, cutting an estimated $5.94M.
- Waycross Partners fully exited Thermo Fisher Scientific in Q3 2024, selling an estimated $13.8M.
- Waycross Partners's ten largest holdings make up 48% of its $723M portfolio in Q3 2024.
- Waycross Partners opened 3 new positions and closed 9 in Q3 2024.
- Waycross Partners's portfolio value rose 11% quarter-over-quarter to $723M.
Based on Waycross Partners's 13F filing for Q3 2024, filed 8 Nov 2024.